Health
The Advisory Committee on the Safety of Medicines (ACSOM) was established in January 2010 to advise and make recommendations to the TGA on the safety, risk assessment, and risk management of medicines. The ACSOM may also provide advice to the TGA on other matters relating to the detection, assessment, understanding, and prevention of adverse effects (known as pharmacovigilance), and any other matters referred to it by the TGA. The ACSOM supersedes and expands upon the role of the Adverse Drug Reactions Advisory Committee, with an increased focus on the safety aspects of medicine regulation and the detection, assessment, understanding, and prevention of adverse effects.

Further information

  • Type of Body

    E. Statutory Office Holder Offices and Committees

  • Established By / Under

    Act / Regulation

  • Established By/Under More info

    Therapeutic Goods Regulations 1990

  • Paid Members?

    Yes

  • Max No. of Board/Committee Members

    25

  • Annual Report Prepared and tabled?

    No

  • Classification

    B. Secondary

  • Creation Date

    1 January 2010

Last updated: